Sutter Neuroscience Institute Launches Groundbreaking Clinical Trial on Autism

Posted on Aug 21, 2012 in Research

In partnership with Cord Blood Registry, the the world’s largest stem cell bank, Sutter Neuroscience Institute started the first FDA-approved clinical trial to study the use of a child’s own newborn stems cells in treatment for patients with autism.

This first-of-its-kind medical research comes at at a time when autism is said to effect one in 88 children in the United States, and one in 54 boys, according to the Centers for Disease Control and Prevention. Although the condition is thought to have multiple risk factors, including genetic, environmental and immunological components, the study will evaluate the ability of an infusion of cord blood stem cells to help improve language and behavior.

Read more on Sutter Medical Center, Sacramento’s newsroom.

Posted by on Aug 21, 2012 in Research | Comments Off on Sutter Neuroscience Institute Launches Groundbreaking Clinical Trial on Autism